HLA

This exploratory, open-label, phase 1-anti-HLA anti body levels and improve transplantation rates.

本项前瞻性 、 开放性、前1 、 2阶段、单中心的研究验证静注免疫球蛋白联用利妥昔单抗是否能够减少抗HLA抗体 的水平和提高移植成功率.

Study on the expression of HLA-DR antigens in alopecia areata lesions.

HLA -DR 抗原在斑秃皮损中的表达.

Moreover , HLA-DQA 1 allelic distribution and association with diseases should be paid great attention.

其中HLA-DQA1 等位基因的分布及其与疾病关联受到很大的关注.

Conclusion FCM is a rapid and reliable method for determination of HLA-B 27.

结论FCM法 是一种快捷、简便、高效的HLA-B27检测方法,适合于临床应用.

Objective : To investigate the expression of HLA? DR and CD 45 Ro in the lesions of allergic contact dermatitis ( ACD ).

目的: 观察HLA? DR和CD45Ro抗原在过敏性接触性皮炎 ( ACD ) 患者皮损细胞上的表达.

Objective To Compare the features of HLA-B 27 antigen detection applied to ankylosing spondylitis ( AS ).

目的比较强直性脊柱炎 ( AS ) 患者HLA-B27检测方法的特点.

The frequency of HLA-DR phenotype and difference between two groups were analyzed.

计算HLA -DR 抗原各型别出现频率并分析其在两组间的差别.

The therapeutic vaccine could induce strong specific CTL activity in HLA-A 2 transgenic mice.

其在HLA-A2转基因鼠中可诱导出强的表位特异性细胞毒性T淋巴细胞活性.

Conclusion Perhaps PPT is not associated with HLA-DP and HLA-DQ alleles.

结论产后甲状腺炎与HLA-DP、HLA-DQ位点可能无相关性.

This solution extends the application domains of HLA.

该方法扩展了HLA的应用领域.

Flow cytometry analysis indicated that the tetramer could bind to specific CTL from HLA-A 11 + donor.

流式细胞仪分析显示所制备的四聚体可与HLA-A11+供者的抗原特异性CTL结合.

Simulation system adopt HLA frame structure, join federal member in interface standard.

该系统采用HLA框架结构, 接口规范通过调用接口联接联邦成员.

HLA-DR ~ + antigen presenting cells ( APC ) reduced remarkably in the SARS spleen white pulp.

脾白髓中HLA-DR+抗原呈递细胞明显减少.

One of the alleles found predominantly in LTNPs is HLA-B 27.

在这些长期不进展者上发现的最显著的等位基因之一就是HLA-B27.

Objective To investigate the expression change histocompatibility antigen-G 5 ( HLA-G 5 ) in one heart recipient.

目的研究心脏移植受者外周血HLA-G5表达变化.